The Topical composition with active compounds from Cannabis sativa and Calendula officinalis for reduction of skin lesions
| Other(s) | ||
|---|---|---|
Šiurkus, Juozas | ||
| Date |
|---|
2022-05-27 |
Int.Cl. A61K36/28, A61K36/886, A61K36/63, A61K36/185, A61K8/41, A61K8/97, A61K8/36, A61K8/34, A61K8/81, A61K9/06, A61Q19/00, A61K8/37, A61K8/67, A61K8/92, A61Q17/04, A61K8/9789, A61P17/06, A61P17/02, A61K9/00, A61K31/192, A61K47/10, A61K47/14, A61K47/18, A61K47/22, A61K47/32, A61K47/44; filing date: 05.27.2022
Related patent documents: EP3439678 (A1), LT2016044 (A), LT6485 (B), US11364273 (B2), US2019111093 (A1), WO2017175126 (A1)
Bibliogr.: p. 6-8
Disclosed is a topical composition including essential combination of synergistically acting phyto-active materials, non-psychotropic phytocannabinoids from the plant of Cannabis sativa: Cannabidiol, Cannabidiolic acid, Cannabivarin Cannabigerol in combination with extract of Calendula flower and the formulation of the base to ensure the features of anti-inflammation, anti-oxidation, emollient, and bactericidal components. The topical composition is an emollient dedicated for reduction of skin lesions caused by atopic dermatitis, urticaria, radiotherapy and UV induced skin damage and acne. In addition the topical composition could reduce secretion of fats, facilitate deep skin hydration, reduce pores and exert soothing effect.